Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer

Gynecologic Oncology

Volumn 132, Issue 2, 2014, Pages 351-359

  Ciucci, Alessandra ^a   Zannoni, Gian Franco ^a   Travaglia, Daniele ^a   Petrillo, Marco ^a   Scambia, Giovanni ^a   Gallo, Daniela ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Epithelial ovarian carcinomas; Estrogen; Estrogen receptor beta; Estrogen receptors; Ovary; Survival

Indexed keywords

EPITHELIAL OVARIAN CARCINOMAS; ESTROGEN; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTORS; OVARY; SURVIVAL;

ADULT; AGED; ANIMALS; CELL LINE, TUMOR; CYSTADENOCARCINOMA, SEROUS; ESTROGEN RECEPTOR BETA; FEMALE; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; PROTEIN ISOFORMS; SURVIVAL ANALYSIS;

EID: 84894055494     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.12.027     Document Type: Article

References (38)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. N. Colombo, T. Van Gorp, G. Parma, F. Amant, G. Gatta, and C. Sessa et al. Ovarian cancer Crit Rev Oncol Hematol 60 2006 159 179
3. H.A. Risch Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone J Natl Cancer Inst 90 1998 1774 1786
4. R.F. Ozols, S.C. Rubin, G.M. Thomas, and S.J. Robboy Epithelial ovarian cancer W.J. Hoskins, W.A. Mitchell, M.E. Randall, M. Markman, R.R. Barakat, R.C. Young, C.A. Perez, Principles and Practice of Gynecologic Oncology 2005 Lippincott Williams & Wilkins 895 988 [Chapter 25]
5. D. Gallo, I. De Stefano, M.G. Prisco, G. Scambia, and G. Ferrandina Estrogen receptor beta in cancer: an attractive target for therapy Curr Pharm Des 18 2012 2734 2757
6. R.J. Pietras, and D.C. Márquez-Garbán Membrane-associated estrogen receptor signaling pathways in human cancers Clin Cancer Res 13 2007 4672 4676
7. L. Björnström, and M. Sjöberg Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes Mol Endocrinol 19 2005 833 842
8. J.T. Moore, D.D. McKee, K. Slentz-Kesler, L.B. Moore, S.A. Jones, and E.L. Horne et al. Cloning and characterization of human estrogen receptor beta isoforms Biochem Biophys Res Commun 247 1998 75 78
9. F. Suzuki, J. Akahira, I. Miura, T. Suzuki, K. Ito, and S. Hayashi et al. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5′-untranslated region in human epithelial ovarian carcinoma Cancer Sci 99 2008 2365 2372
10. I. De Stefano, G.F. Zannoni, M.G. Prisco, A. Fagotti, L. Tortorella, and G. Vizzielli et al. Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer Gynecol Oncol 122 2011 573 579
11. G.J. Rustin Use of CA-125 to assess response to new agents in ovarian cancer trials J Clin Oncol 21 2003 187 193
12. G.J. Rustin, M. Quinn, T. Thigpen, A. du Bois, E. Pujade-Lauraine, and A. Jakobsen et al. Re: new guidelines to evaluate the response to treatment in solid tumors (ovarian cancer) J Natl Cancer Inst 96 2004 487 488
13. T. Thigpen A rational approach to the management of recurrent or persistent ovarian carcinoma Clin Obstet Gynecol 55 2012 114 130
14. N.A. Wong, R.D. Malcomson, D.I. Jodrell, N.P. Groome, D.J. Harrison, and P.T. Saunders ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates J Pathol 207 2005 53 60
15. A.M. Shaaban, A.R. Green, S. Karthik, Y. Alizadeh, T.A. Hughes, and L. Harkins et al. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients Clin Cancer Res 14 2008 5228 5235
16. F. Collins, S. MacPherson, P. Brown, V. Bombail, A.R. Williams, and R.A. Anderson et al. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha BMC Cancer 16 2009 330 342
17. M. Yan, M. Rayoo, E.A. Takano, kConFab Investigators, and S.B. Fox Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers Breast Cancer Res Treat 126 2011 395 405
18. G.F. Zannoni, G. Monterossi, I. De Stefano, A. Gargini, M.G. Salerno, and I. Farulla et al. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer Hum Pathol 44 2013 1047 1054
19. X. Wu, M. Subramaniam, V. Negron, M. Cicek, C. Reynolds, and W.L. Lingle et al. Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody J Cell Biochem 113 2012 711 723
20. M.A. Hayat Estrogens Microscopy, immunohistochemistry, and antigen retrieval methods for light and electron microscopy 2002 Kluwer Academic/Plenum Publishers New York, NY 276 277
21. R. Emig, A. Magener, V. Ehemann, A. Meyer, F. Stilgenbauer, and M. Volkmann et al. Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation Br J Cancer 78 1998 1661 1668
22. R. von Wasielewski, M. Mengel, B. Wiese, T. Rüdiger, H.K. Müller-Hermelink, and H. Kreipe Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial Am J Clin Pathol 118 2002 675 682
23. N. Shabani, C. Kuhn, S. Kunze, S. Schulze, D. Mayr, and D. Dian et al. Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas Eur J Cancer 43 2007 2434 2444
24. A. Burges, A. Brüning, C. Dannenmann, T. Blankenstein, U. Jeschke, and N. Shabani et al. Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary Arch Gynecol Obstet 281 2010 511 517
25. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia (second edition) Br J Cancer 77 1998 1 10
26. T. Corbett, F. Valeriote, P. LoRusso, L. Polin, C. Panchapor, and S. Pugh et al. In vivo methods for screening and preclinical testing B.A. Teicher, Anticancer drug development guide 1997 Humana Press Totowa, New Jersey 75 99
27. D. Gallo, G.F. Zannoni, I. De Stefano, M. Mosca, C. Ferlini, and E. Mantuano et al. Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice J Nutr 138 2008 1360 1364
28. G. Pandini, M. Genua, F. Frasca, S. Squatrito, R. Vigneri, and A. Belfiore 17Beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells Cancer Res 67 2007 8932 8941
29. G. Zhang, X. Liu, A.M. Farkas, A.V. Parwani, K.L. Lathrop, and D. Lenzner et al. Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells Mol Endocrinol 23 2009 146 156
30. J.W. Simpkins, S.H. Yang, S.N. Sarkar, and V. Pearce Estrogen actions on mitochondria - physiological and pathological implications Mol Cell Endocrinol 290 2008 51 59
31. G. Zhang, N. Yanamala, K.L. Lathrop, L. Zhang, J. Klein-Seetharaman, and H. Srinivas Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells Mol Endocrinol 24 2010 1737 1747
32. J.Q. Chen, P.R. Cammarata, C.P. Baines, and J.D. Yager Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications Biochim Biophys Acta 1793 2009 1540 1570
33. S.H. Yang, S.N. Sarkar, R. Liu, E.J. Perez, X. Wang, and Y. Wen et al. Estrogen receptor beta as a mitochondrial vulnerability factor J Biol Chem 284 2009 9540 9548
34. R.Z. Yusuf, Z. Duan, D.E. Lamendola, R.T. Penson, and M.V. Seiden Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation Curr Cancer Drug Targets 3 2003 1 19
35. L. Kelland The resurgence of platinum-based cancer chemotherapy Nat Rev Cancer 7 2007 573 584
36. J. Häring, S. Schüler, C. Lattrich, O. Ortmann, and O. Treeck Role of estrogen receptor β in gynecological cancer Gynecol Oncol 127 2012 673 676
37. K.K. Chan, N. Wei, S.S. Liu, L. Xiao-Yun, A.N. Cheung, and H.Y. Ngan Estrogen receptor subtypes in ovarian cancer: a clinical correlation Obstet Gynecol 111 2008 144 151
38. S. Domcke, R. Sinha, D.A. Levine, C. Sander, and N. Schultz Evaluating cell lines as tumour models by comparison of genomic profiles Nat Commun 4 2013 2126